Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients

Mark R. Albertini, Jacquelyn A. Hank, Joan H. Schiller, Masoud Khorsand, Agnes A. Borchert, Jacek Gan, Robin Bechhofer, Barry Storer, Ralph A. Reisfeld, Paul M. Sondel

Research output: Contribution to journalArticle

68 Scopus citations

Fingerprint Dive into the research topics of 'Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients'. Together they form a unique fingerprint.

Medicine & Life Sciences